Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,320 | 172 | 97.4% |
| Education | $87.27 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $833.05 | 42 | $0 (2024) |
| Almirall LLC | $360.89 | 28 | $0 (2019) |
| GENZYME CORPORATION | $309.70 | 14 | $0 (2024) |
| Aqua Pharmaceuticals | $281.12 | 16 | $0 (2017) |
| Janssen Biotech, Inc. | $175.19 | 6 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $169.83 | 8 | $0 (2020) |
| PFIZER INC. | $156.25 | 8 | $0 (2024) |
| Biofrontera Inc. | $145.72 | 9 | $0 (2024) |
| EPI Health, LLC | $137.12 | 4 | $0 (2020) |
| Lilly USA, LLC | $134.04 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.94 | 13 | Novartis Pharmaceuticals Corporation ($93.80) |
| 2023 | $341.86 | 18 | Novartis Pharmaceuticals Corporation ($178.95) |
| 2022 | $148.46 | 7 | Novartis Pharmaceuticals Corporation ($133.96) |
| 2021 | $177.96 | 9 | Novartis Pharmaceuticals Corporation ($90.40) |
| 2020 | $240.39 | 9 | Novartis Pharmaceuticals Corporation ($59.79) |
| 2019 | $838.87 | 44 | Janssen Biotech, Inc. ($140.74) |
| 2018 | $682.26 | 35 | Almirall LLC ($231.52) |
| 2017 | $739.34 | 39 | Aqua Pharmaceuticals ($281.12) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.31 | General |
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.56 | General |
| 07/25/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $11.49 | General |
| Category: DERMATOLOGY | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Dermatology | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Immunology | ||||||
| 04/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.33 | General |
| 02/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Dermatology | ||||||
| 01/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Dermatology | ||||||
| 01/02/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $13.38 | General |
| 12/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: Dermatology | ||||||
| 11/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Immunology | ||||||
| 10/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 10/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Dermatology | ||||||
| 08/30/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Dermatology | ||||||
| 08/08/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Dermatology | ||||||
| 07/20/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Immunology | ||||||
| 06/23/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Dermatology | ||||||
| 06/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Immunology | ||||||
| 05/23/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Immunology | ||||||
| 05/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Dermatology | ||||||
| 04/11/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 5,352 | 16,047 | $1.9M | $882,580 |
| 2022 | 24 | 5,237 | 15,133 | $1.9M | $916,463 |
| 2021 | 25 | 4,967 | 15,788 | $1.6M | $884,987 |
| 2020 | 24 | 4,389 | 11,565 | $1.2M | $661,524 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 1,115 | 1,868 | $339,135 | $183,938 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 956 | 1,440 | $250,416 | $134,510 | 53.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 512 | 831 | $256,322 | $122,644 | 47.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 82 | 209 | $160,247 | $79,197 | 49.4% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 82 | 96 | $120,749 | $58,438 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 417 | 777 | $90,932 | $56,147 | 61.7% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 60 | 138 | $97,808 | $49,894 | 51.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 60 | 75 | $86,297 | $41,804 | 48.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 581 | 881 | $120,459 | $29,738 | 24.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 524 | 4,459 | $63,452 | $27,555 | 43.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 286 | 326 | $58,390 | $20,144 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 138 | 138 | $36,678 | $16,808 | 45.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 227 | 660 | $72,387 | $12,827 | 17.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 57 | 84 | $24,531 | $12,523 | 51.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 14 | 15 | $10,221 | $5,305 | 51.9% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 17 | 19 | $7,250 | $5,055 | 69.7% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 22 | 28 | $8,973 | $4,938 | 55.0% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 17 | 3,800 | $9,166 | $4,933 | 53.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $9,392 | $4,502 | 47.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 23 | 27 | $8,505 | $4,206 | 49.5% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 17 | 19 | $4,468 | $2,282 | 51.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 45 | 52 | $5,005 | $1,929 | 38.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 27 | $4,219 | $1,255 | 29.8% |
| 11423 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 13 | 13 | $4,521 | $1,017 | 22.5% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 12 | $3,846 | $990.99 | 25.8% |
About Dr. Ann Vu, MD
Dr. Ann Vu, MD is a Dermatology healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497848295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Vu, MD has received a total of $3,407 in payments from pharmaceutical and medical device companies, with $237.94 received in 2024. These payments were reported across 174 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,320).
As a Medicare-enrolled provider, Vu has provided services to 19,945 Medicare beneficiaries, totaling 58,533 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Newport Beach, CA
- Active Since 10/02/2006
- Last Updated 12/07/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497848295
Products in Payments
- COSENTYX (Biological) $560.30
- COSENTYX (Drug) $272.75
- Xolegel (Drug) $201.31
- DUPIXENT (Biological) $180.58
- Veltin (Drug) $144.85
- EUCRISA (Drug) $140.98
- Tremfya (Drug) $137.60
- Sitavig (Drug) $137.12
- TALTZ (Drug) $134.04
- Enbrel (Biological) $114.02
- XIFAXAN (Drug) $107.00
- Cordran (Drug) $95.39
- Seysara (Drug) $77.09
- DERMATITIS - DISEASE (Drug) $74.00
- Ameluz (Drug) $72.88
- AMELUZ (Drug) $72.84
- Absorica (Drug) $67.52
- Humira (Biological) $64.60
- RINVOQ (Biological) $63.12
- DORYX (Drug) $60.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Newport Beach
Dr. Kevin Belasco, D.o, D.O
Dermatology — Payments: $548,524
Dr. Navid Nami, D.o, D.O
Dermatology — Payments: $279,831
Dr. Monica Bonakdar, Md, MD
Dermatology — Payments: $245,823
Dr. Zenovia Gabriel, Md, MD
Dermatology — Payments: $36,839
Neda Mehr, M.d, M.D
Dermatology — Payments: $12,974
Melissa Watcher, M.d, M.D
Dermatology — Payments: $11,064